The Sentec suite of attachment options for transcutaneous CO2 monitoring allows care teams to confidently choose solutions that support the clinical priorities of each patient — across populations and care settings.

Learn more about how a level IV NICU team was recently successful in developing an all-encompassing strategy to drive consistent utilization of transcutaneous monitoring with the goal of improving patient care.

In NICUs, PICUs, and sleep labs around the world, transcutaneous monitoring has increasingly become a trusted tool for continuous, noninvasive CO2 measurement. The technology can help reduce the need for frequent blood draws, enable proactive ventilator management, and offer additional benefits as care teams support diverse patient populations.

In the Pediatric Sleep Center at Nemours Children’s Hospital, transcutaneous CO2 monitoring is a valuable tool that we use for both routine and complex cases.

A growing body of research raises an important question: Are patients with chronic hypercapnic respiratory failure being adequately managed? For these individuals, the presence of elevated CO2 levels alongside normal or near-normal pH levels — a result of renal compensation — is often overlooked.

Diagnosed with spinal muscular atrophy shortly after birth, Stella relies on intrapulmonary percussive ventilation (IPV) therapy as a key part of her daily routine. By offering a proactive approach to her at-home respiratory care, IPV therapy empowers Stella and her family to embrace an active and fulfilling lifestyle with confidence.

With product features designed for the sleep lab, the Sentec Transcutaneous Monitoring System combines ease of use and patient comfort with accurate values regardless of ventilation method or ventilation perfusion (V/Q) mismatch.

Chronic hypercapnia, characterized by elevated levels of CO2, poses a significant challenge for individuals with conditions like chronic obstructive pulmonary disease (COPD), neuromuscular disorders (NMD), and obesity. Although the negative effects of chronic hypercapnia are widely acknowledged, researchers at the University of Michigan are shedding light on the true urgency of its management.

Intrapulmonary percussive ventilation (IPV) therapy is an airway clearance therapy that combines percussion, high-velocity flow, and entrainment to mobilize secretions and address gas exchange impairment. The therapy can be delivered through a mouthpiece or mask, directly to the airway, or in-line with a ventilator, making it versatile for a range of patient populations.

The IPV 1 is a safe and effective airway clearance device that builds on the Percussionaire legacy of IPV therapy with a Unified Connector that supports patient safety, a patient-friendly interface, and the unique efficacy of the Phasitron.